Target intelligence / Profile preview

Exogenous toxins

Molecular classification
Other
01

Overview

Exogenous toxins are a broad and heterogeneous class of substances originating outside the organism that cause harm upon entry into the body (StatPearls, 2023). This category includes biological toxins such as those produced by bacteria (e.g., botulinum toxin), fungi (e.g., aflatoxin), plants (e.g., ricin), and animals (e.g., snake venom), as well as non-biological chemical agents like heavy metals and environmental pollutants (NIH, 2022). These substances exert their effects by binding to specific host receptors, inhibiting vital enzymes, or disrupting cellular membranes, leading to a wide range of pathological conditions from acute poisoning to chronic organ damage (PubChem, 2024). In pharmacology, exogenous toxins are typically the targets of neutralizing therapies such as antitoxins, antivenoms, and chelating agents, which aim to sequester or chemically modify the toxin to prevent its interaction with host tissues (Wikipedia, 2024). Because the term refers to a functional category of diverse molecules rather than a single molecular entity, it is not considered a specific therapeutic target in standard drug discovery nomenclature.

Other names
XenobioticsBiotoxinsEnvironmental toxinsExotoxinsForeign toxins
02

Mechanism of action

Neutralization by binding (antibodies), chemical chelation of metal ions, or competitive antagonism at host receptor sites.

03

Biological functions

Cell deathOther
04

Disease associations

InfectionOther
05

Safety considerations

Immunogenicity of biological antitoxinsOff-target chelation of essential mineralsIncomplete neutralization of the toxin
06

Interacting drugs

Digoxin Immune Fab

7 more in the full profile.

07

Biomarkers

Serum toxin concentrationUrinary metabolite levelsSpecific enzyme activity (e.g., acetylcholinesterase for organophosphates)

Beyond the preview

Go deeper on Exogenous toxins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Exogenous toxins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call